Vanguard Group Inc Nuvation Bio Inc. Transaction History

Vanguard Group Inc

  • $4.96 Trillion
  • Q1 2024

A detailed history of Vanguard Group Inc transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 7,534,148 shares of NUVB stock, worth $22.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,534,148
Previous 7,314,615 3.0%
Holding current value
$22.9 Million
Previous $11 Million 148.29%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$1.46 - $3.97 $320,518 - $871,546
219,533 Added 3.0%
7,534,148 $27.4 Million
Q4 2023

Feb 14, 2024
BUY
$0.96 - $1.53 $17,718 - $28,239
18,457 Added 0.25%
7,314,615 $11 Million
Q3 2023

Nov 14, 2023
BUY
$1.26 - $2.1 $21,568 - $35,947
17,118 Added 0.24%
7,296,158 $9.78 Million
Q2 2023

Aug 14, 2023
BUY
$1.56 - $1.84 $119,455 - $140,896
76,574 Added 1.06%
7,279,040 $13.1 Million
Q1 2023

May 15, 2023
SELL
$1.6 - $2.48 $4.37 Million - $6.77 Million
-2,729,975 Reduced 27.49%
7,202,466 $12 Million
Q4 2022

Feb 10, 2023
SELL
$1.68 - $2.5 $4.56 Million - $6.78 Million
-2,712,010 Reduced 21.45%
9,932,441 $19.1 Million
Q3 2022

Nov 14, 2022
BUY
$0.29 - $4.04 $3,425 - $47,724
11,813 Added 0.09%
12,644,451 $28.3 Million
Q2 2022

Aug 12, 2022
SELL
$3.24 - $5.85 $971,423 - $1.75 Million
-299,822 Reduced 2.32%
12,632,638 $40.9 Million
Q1 2022

May 13, 2022
BUY
$4.6 - $8.83 $7.69 Million - $14.8 Million
1,671,908 Added 14.85%
12,932,460 $68 Million
Q4 2021

Feb 14, 2022
SELL
$7.75 - $10.05 $4.98 Million - $6.45 Million
-641,975 Reduced 5.39%
11,260,552 $95.7 Million
Q3 2021

Nov 12, 2021
BUY
$7.78 - $10.0 $6.27 Million - $8.06 Million
806,166 Added 7.27%
11,902,527 $118 Million
Q2 2021

Aug 13, 2021
BUY
$9.22 - $14.48 $102 Million - $161 Million
11,096,361 New
11,096,361 $103 Million

Others Institutions Holding NUVB

# of Institutions
126
Shares Held
107M
Call Options Held
40.6K
Put Options Held
2.9K
View Full List

About Nuvation Bio Inc.

NUVB Quotes by TradingView
  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $660M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email